Technology | Breast Imaging | December 14, 2016

Zero-footprint enterprise viewing platform can now be used for viewing diagnostic mammography and tomosynthesis images

Client Outlook, eUnity enterprise image viewing platform, FDA clearance, diagnostic mammography reading

December 14, 2016 — Client Outlook announced in November that the U.S. Food and Drug Administration has cleared its eUnity viewing platform for diagnostic reading of mammography images.

eUnity is an advanced, scalable, zero-footprint diagnostic enterprise image viewing platform that allows healthcare providers to access, manipulate and collaborate over full diagnostic-quality medical images without the need for expensive GPU-based hardware. Already used for radiology reading at many healthcare enterprises, providers can now use eUnity to diagnose mammography and breast tomography images, all from a single viewing platform.

For more information: www.clientoutlook.com


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
Feature | Artificial Intelligence | Jordan Bazinsky

For the past decade, artificial intelligence's (AI) potential in healthcare has been synonymous with speed. In medical ...

Time February 16, 2026
arrow
Subscribe Now